|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$22,472
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
Comprehensive Cancer Center Core Support Grant
|
5P30CA013148-41
|
$5,120,370
|
$51,204
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cancer Center Support Grant
|
5P30CA023108-35
|
$2,922,577
|
$58,452
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Stanford University Cancer Center
|
5P30CA124435-07
|
$2,890,663
|
$28,907
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant (CCSG)
|
5P30CA086862-13
|
$2,309,996
|
$23,100
|
WEINER, GEORGE
|
UNIVERSITY OF IOWA
|
|
Endogenous Nitrite Carcinogenesis in Man
|
5P01CA026731-34
|
$1,642,348
|
$82,117
|
Tannenbaum, Steven
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,624,711
|
$324,942
|
Gress, Ronald
|
CCR (NCI)
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
5P30CA051008-20
|
$1,449,710
|
$14,497
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
|
ZIA SC 004002
|
$1,388,882
|
$138,888
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$1,345,130
|
$67,257
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-05
|
$1,310,169
|
$26,203
|
KRAFT, ANDREW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIA BC 005270
|
$1,306,961
|
$196,044
|
Blumberg, Peter
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,287,528
|
$64,376
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$1,048,784
|
$157,318
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$944,029
|
$75,522
|
Kleiner, David
|
CCR (NCI)
|
|
Control of Cytokine Gene Expression in Lymphoid/Myeloid Cells
|
ZIA BC 009283
|
$874,946
|
$874,946
|
Young, Howard
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$845,663
|
$84,566
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
|
ZIA BC 009369
|
$781,150
|
$156,230
|
Oppenheim, Joost
|
CCR (NCI)
|
|
TNF Signaling and Cell Death
|
ZIA SC 010376
|
$736,598
|
$73,660
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$721,737
|
$108,260
|
Carrington, Mary
|
CCR (NCI)
|
|
Xenobiotic Receptors
|
ZIA BC 005708
|
$707,692
|
$212,308
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Role of inflammation, innate resistance, and immunity in carcinogenesis.
|
ZIA BC 010793
|
$624,641
|
$124,928
|
Trinchieri, Giorgio
|
CCR (NCI)
|
|
Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages
|
ZIA BC 010300
|
$588,689
|
$58,869
|
McVicar, Daniel
|
CCR (NCI)
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$584,855
|
$175,456
|
Hakim, Frances
|
CCR (NCI)
|
|
Cell-free assay technologies for the identification of active compounds
|
ZIA BC 011471
|
$583,633
|
$192,599
|
O'Keefe, Barry
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$582,141
|
$29,107
|
Arthur, Diane
|
CCR (NCI)
|
|
Resequencing and Functional Studies to Identify Causal Gene Variants of Lymphoma
|
5R01CA154643-04
|
$582,094
|
$145,524
|
Skibola, Christine
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases
|
ZIA SC 003657
|
$565,971
|
$424,478
|
Katz, Stephen
|
CCR (NCI)
|
|
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)
|
5R01CA170653-02
|
$550,881
|
$137,720
|
BYERS, STEPHEN
|
GEORGETOWN UNIVERSITY
|
|
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort
|
5R01CA140754-04
|
$523,362
|
$523,362
|
Johnson, Christine C
|
HENRY FORD HEALTH SYSTEM
|
|
Cytokines and T Cell Development
|
ZIA BC 009287
|
$456,070
|
$91,214
|
Durum, Scott
|
CCR (NCI)
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$436,452
|
$218,226
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Epidemiology of Cancer in a Cohort of Older Women
|
5R01CA039742-29
|
$414,310
|
$82,862
|
LAZOVICH, DEANN
|
UNIVERSITY OF MINNESOTA
|
|
Cancer risk among Japanese A-bomb survivors
|
ZIA CP010134-04016
|
$412,577
|
$82,515
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
|
ZIA BC 010955
|
$407,615
|
$81,523
|
Hurwitz, Arthur
|
CCR (NCI)
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$401,053
|
$80,211
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Nitroxides as Protectors Against Oxidative Stress
|
ZIA SC 006387
|
$389,114
|
$194,557
|
Mitchell, James
|
CCR (NCI)
|
|
Biology and Therapy of Lymphopenia
|
ZIA BC 011069
|
$368,049
|
$220,829
|
Mackall, Crystal
|
CCR (NCI)
|
|
In vivo targeting of hematopoetic cells with glycan ligands of siglecs
|
5R01CA138891-04
|
$354,146
|
$88,537
|
PAULSON, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
Identification of Gene Polymorphisms Associated with Infectious Diseases
|
ZIA BC 010297
|
$344,514
|
$3,445
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Roles of Glycoconjugates and Redox Signaling in Tumor Biology
|
ZIA SC 009174
|
$338,669
|
$67,734
|
Roberts, David
|
CCR (NCI)
|
|
Sulfatide-reactive type II NKT cells: repertoire and function
|
5R01CA100660-09
|
$328,591
|
$328,591
|
Kumar, Vipin
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
|
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer
|
7R01CA151304-03
|
$307,633
|
$76,908
|
Hofseth, Lorne
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
Mechanisms of Alteration of B Lymphocyte Function by LMP1
|
5R01CA099997-10
|
$304,205
|
$76,051
|
BISHOP, GAIL
|
UNIVERSITY OF IOWA
|
|
Engineering Triggered Nanomechanical Therapeutics
|
5R01CA140759-05
|
$303,525
|
$91,058
|
PIERCE, NILES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Role of T regulatory suppression in autoimmunity and cancer
|
ZIA BC 010707
|
$278,982
|
$55,796
|
Oppenheim, Joost
|
CCR (NCI)
|
|
NK Cell Biology
|
5R01CA095137-10
|
$271,415
|
$135,708
|
LANIER, LEWIS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$263,161
|
$263,161
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Regulation and Consequences of Ubiquitination
|
ZIA BC 010779
|
$263,161
|
$52,632
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Glucocorticoids and T cell development and function
|
ZIA BC 011264
|
$263,161
|
$263,161
|
Ashwell, Jonathan
|
CCR (NCI)
|
Total relevant funding to Autoimmune Diseases for this search: $8,954,025
|